SEARCH

SEARCH BY CITATION

References

  • Afford SC, Randhawa S, Eliopoulos AG, Hubscher SG, Young LS and Adams DH (1999) CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection. J Exp Med, 189, 441446.
  • Alexander-Miller MA, Derby MA, Sarin A, Henkart PA and Berzofsky JA (1998) Supraoptimal peptide–major histocompatibility complex causes a decrease in Bc1-2 levels and allows tumor necrosis factor α receptor II-mediated apoptosis of cytotoxic T lymphocytes. J Exp Med, 188, 13911399.
  • Amakawa R et al. (1996) Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell, 84, 551562.
  • Arch RH, Gedrich RW and Thompson CB (1998) Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulate life and death. Genes Dev, 12, 28212830.
  • Ashkenazi A and Dixit VM (1998) Death receptors: signaling and modulation. Science, 281, 13051308.
  • Black RA et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature, 385, 729733.
  • Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH and Wallach D (1995) Self-association of the ‘death domains’ of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem, 270, 387391.
  • Boldin MP, Goncharov TM, Goltsev YV and Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell, 85, 803815.
  • Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W and Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA, 87, 31273131.
  • Browning JL, Miatkowski K, Sizing I, Griffiths D, Zafari M, Benjamin CP, Meier W and Mackay F (1996) Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J Exp Med, 183, 867878.
  • Clark EA and Ledbetter JA (1986) Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA, 83, 44944498.
  • Duckett CS and Thompson CB (1997) CD30-dependent degradation of TRAF2—implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev, 11, 28102821.
  • Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bornkamm GW and Holler E (1995) Critical involvement of transmembrane tumor necrosis factor-α in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood, 86, 41844193.
  • Eliopoulos AG et al. (1996) CD40-induced growth inhibition in epithelial cells is mimicked by Epstein–Barr virus-encoded LMP1—involvement of TRAF3 as a common mediator. Oncogene, 13, 22432254.
  • Fiers W (1993) Tumor necrosis factor. In Sim,E. (ed.), The Natural Immune System: Humoral Factors. IRL Press, Oxford, UK, pp. 65119.
  • Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FG and Karpas A (1988) A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor β-chain gene. Blood, 72, 234240.
  • Grell M and Clauss M (1999) TNF and TNF receptor superfamily. Int Rev Immunol., in press.
  • Grell M, Scheurich P, Meager A and Pfizenmaier K (1993) TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res, 12, 143148.
  • Grell M, Zimmermann G, Hülser D, Pfizenmaier K and Scheurich P (1994) TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol, 153, 19631972.
  • Grell M et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell, 83, 793802.
  • Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P and Korsmeyer SJ (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem, 274, 11561163.
  • Haridas V, Darnay BG, Natarajan K, Heller R and Aggarwal BB (1998) Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation and c-Jun kinase activation. J Immunol, 160, 31523162.
  • Heller RA, Song K, Fan N and Chang DJ (1992) The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell, 70, 4756.
  • Hess S and Engelmann H (1996) A novel function of CD40: induction of cell death in transformed cells. J Exp Med, 183, 159167.
  • Huang DCS, Cory S and Strasser A (1997) Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene, 14, 405414.
  • Itoh N and Nagata S (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem, 268, 1093210937.
  • Jacobson MD, Weil M and Raff MC (1997) Programmed cell death in animal development. Cell, 88, 347354.
  • Jongeneel CV (1995) Transcriptional regulation of the tumor necrosis factor α gene. Immunobiology, 193, 210216.
  • Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A and Green DR (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol Cell, 1, 543551.
  • Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J, 14, 55795588.
  • Lee SY, Park CG and Choi Y (1996) T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med, 183, 669674.
  • Li H, Zhu H, Xu CJ and Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94, 491501.
  • Luo X, Budihardjo I, Zou H, Slaughter C and Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptor. Cell, 94, 481490.
  • McCarthy JV, Ni J and Dixit VM (1998) RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J Biol Chem, 273, 1696816975.
  • Nagata S (1997) Apoptosis by death factor. Cell, 88, 355365.
  • Sarin A, Conan-Cibotti M and Henkart PA (1995) Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol, 155, 37163718.
  • Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J, 17, 16751687.
  • Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A and Tschopp J (1998) Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med, 187, 12051213.
  • Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M and Diehl V (1982) Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature, 299, 6567.
  • Smith CA et al. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell, 73, 13491360.
  • Smith CA, Farrah T and Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell, 76, 959962.
  • Smith KGC, Strasser A and Vaux DL (1996) CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/Apo-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J, 15, 51675176.
  • Speiser DE, Sebzda E, Ohteki T, Bachmann MF, Pfeffer K, Mak TW and Ohashi PS (1996) Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol, 26, 30553060.
  • Stein H et al. (1985) The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66, 848858.
  • Strasser A (1995) Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr Opin Immunol, 7, 228234.
  • Strasser A and O'Connor L (1998) Fas ligand—caught between Scylla and Charybdis. Nature Med, 4, 2122.
  • Strasser A, Harris AW, Huang DCS, Krammer PH and Cory S (1995) Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J, 14, 61366147.
  • Swantek JL, Cobb MH and Geppert TD (1997) Jun N-terminal kinase stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α translation – glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol, 17, 62746282.
  • Tanaka M, Itai T, Adachi M and Nagata S (1998) Downregulation of Fas ligand by shedding. Nature Med, 4, 3136.
  • Tartaglia LA, Ayres TM, Wong GH and Goeddel DV (1993) A novel domain within the 55 kD TNF receptor signals cell death. Cell, 74, 845853.
  • Thoma B, Grell M, Pfizenmaier K and Scheurich P (1990) Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med, 172, 10191023.
  • Thornberry NA and Lazebnik Y (1998) Caspases—enemies within. Science, 281, 13121316.
  • Thornberry NA et al. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B—functional, relationships established for key mediators of apoptosis. J Biol Chem, 272, 1790717911.
  • VanArsdale TL, VanArsdale SL, Force WR, Walter BN, Mosialos G, Kieff E, Reed JC and Ware CF (1997) Lymphotoxin-β receptor signaling complex—role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc Natl Acad Sci USA, 94, 24602465.
  • Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J and Fiers W (1995) Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol, 154, 29042913.
  • Varfolomeev EE, Boldin MP, Goncharov TM and Wallach D (1996) A potential mechanism of ‘cross-talk’ between the p55 tumor necrosis factor receptor and Fas/Apo1: proteins binding to the death domains of the two receptors also bind to each other. J Exp Med, 183, 12711275.
  • Vercammen D, Vandenabeele P, Declercq W, Van de Craen M, Grooten J and Fiers W (1995) Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Cytokine, 7, 463470.
  • Weiss T, Grell M, Hessabi B, Bourteele S, Müller G, Scheurich P and Wajant H (1997) Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80—requirement of the TNF receptor-associated factor-2 binding site. J Immunol, 158, 23982404.
  • Weiss T, Grell M, Sieminski K, Mühlenbeck F, Dürkop H, Pfizenmaier K, Scheurich P and Wajant H (1998) TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol, 161, 31363142.
  • Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH and Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature, 377, 348351.
  • Zhou T, Edwards CK, Yang P, Wang Z, Bluethmann H and Mountz JD (1996) Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor 1. J Immunol, 156, 26612665.